Central Nervous System Diseases clinical trials at UC Health
2 in progress, 0 open to eligible people
AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Sorry, in progress, not accepting new patients
The CENTAUR trial will be a 2:1 (active:placebo) randomized, double-blind, placebo-controlled Phase II trial to evaluate the safety and efficacy of AMX0035 for the treatment of ALS.
at UC Irvine
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Sorry, in progress, not accepting new patients
Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.
at UCSF
Last updated: